Insulin aspart, recombinant Subcutaneous and Sirturo Tablets
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Sirturo Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: bedaquiline
Brand name: Sirturo
Synonyms: Bedaquiline, Bedaquiline Fumarate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Sitagliptin
- Insulin aspart, recombinant Subcutaneous-Sitagliptin and metformin
- Insulin aspart, recombinant Subcutaneous-Sitagliptin and Metformin Extended-Release Tablets
- Insulin aspart, recombinant Subcutaneous-Sitagliptin and Metformin Tablets
- Insulin aspart, recombinant Subcutaneous-Sitagliptin and simvastatin
- Insulin aspart, recombinant Subcutaneous-Sitagliptin Phosphate
- Sirturo Tablets-Insulin degludec
- Sirturo Tablets-Insulin Degludec (U-100) Prefilled Pens
- Sirturo Tablets-Insulin Degludec (U-100) Vials
- Sirturo Tablets-Insulin Degludec (U-200) Prefilled Pens
- Sirturo Tablets-Insulin degludec and liraglutide
- Sirturo Tablets-Insulin degludec and liraglutide Subcutaneous